Bladder Cancer - Results from #220

Predictive Biomarkers in Bladder Cancer - Beyond the Abstract February 20, 2020

Photodynamic Versus White Light-Guided Treatment of Non-Muscle Invasive Bladder Cancer: A Study Protocol for a Randomised Trial of Clinical and Cost-Effectiveness - Beyond the Abstract February 20, 2020

Orthotopic Neobladder Reconstruction: Patient Selection and Perspectives - Beyond the Abstract February 18, 2020

Neoadjuvant Therapies for Bladder Cancer in Cisplatin-Ineligible Patients: What Options Do We Have? - Beyond the Abstract February 18, 2020

A Simplified Nomogram to Assess Risk of Bladder Cancer in Patients with a New Diagnosis of Microscopic Hematuria - Beyond the Abstract February 12, 2020

Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function - Beyond the Abstract February 12, 2020

Perioperative Outcomes of Open Retrograde Extraperitoneal Versus Intracorporeal Robot-Assisted Radical Cystoprostatectomy in Men: A Dual-center Comparative Study - Beyond the Abstract February 7, 2020

Prognostic Significance of Pre- and Post-Treatment PD-L1 Expression in Patients with Primary High-Grade Non-Muscle-Invasive Bladder Cancer Treated with BCG Immunotherapy - Beyond the Abstract January 31, 2020

A Genetically Defined Disease Model Reveals that Urothelial Cells Can Initiate Divergent Bladder Cancer Phenotypes - Beyond the Abstract January 23, 2020

Increasing Rates of Perioperative Chemotherapy are Associated with Improved Survival in Men with Urothelial Bladder Cancer with Prostatic Stromal Invasion - Beyond the Abstract January 15, 2020

Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation - Beyond the Abstract January 15, 2020

Glycemic Impact of a Diet and Lifestyle Intervention on Diabetics and Prediabetics During Treatment for Non-Muscle Invasive Bladder Cancer - Beyond the Abstract January 14, 2020

Economic Burden of Radical Cystectomy versus Trimodal Therapy in Patients with Localized Muscle-Invasive Bladder Cancer - Beyond the Abstract January 7, 2020

Overview of Taris GemRIS: A Novel Drug Delivery System for Bladder Cancer – Beyond the Abstract December 17, 2019

A Novel Gene Signature Combination Improves the Prediction of Overall Survival in Urinary Bladder Cancer - Beyond the Abstract December 4, 2019

Long Non-coding RNAs Identify A Subset of Luminal Muscle-invasive Bladder Cancer Patients with Favorable Prognosis - Beyond the Abstract November 26, 2019

Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience - Beyond the Abstract October 31, 2019

Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients - A Cross-Sectional Study - Beyond the Abstract October 14, 2019

How Cancer-specific Mortality Changes over Time after Radical Cystectomy: Conditional Survival of Patients with Nonmetastatic Urothelial Carcinoma of the Urinary Bladder - Beyond the Abstract October 2, 2019

Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer - Beyond the Abstract September 13, 2019

Page 12 of 24